Statins cardiovascular data

Researchers at the university reported data from a retrospective analysis of 255 patients who underwent heart transplantations from 1985-2007 and who survived at least 1 year post-transplantation showing that use of statins significantly reduced the risk of developing any cancer by 65% compared to non-use (p=0.0001). Additionally, the cumulative incidence of tumors 8 years post-transplantation was significantly lower in patients receiving a statin compared to patients not receiving a statin (13% vs. 34%, p=0.003), a benefit that persisted at 10 (18% vs. 39%) and 12 years post-transplantation (22% vs. 42%). The researchers also said statin use was associated with improved cancer-free survival and OS vs. non-use (p=0.0001 for both) and that the beneficial effect of statins on preventing cancer and reducing death from all causes was independent of patients' cholesterol levels. Data were presented at the Heart Failure meeting in Belgrade...